(Q41698362)

7 October 2017

1 reference

title

Association of beta 3-adrenoceptor polymorphism with obesity and diabetes: current status (English)

1 reference

7 October 2017

Strosberg AD

1

1 reference

7 October 2017

1 December 1997

1 reference

Trends in Pharmacological Sciences

7 October 2017

1 reference

7 October 2017

18

1 reference

7 October 2017

12

1 reference

7 October 2017

449-454

1 reference

Molecular characterization of the human beta 3-adrenergic receptor

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Structure and function of the beta 3-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Time of Onset of Non-Insulin-Dependent Diabetes Mellitus and Genetic Variation in the β3-Adrenergic–Receptor Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Québec Family Study and Swedish Obese Subjects cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Molecular scanning for mutations in the beta 3-adrenergic receptor gene in Nauruans with obesity and noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Role of the beta 3-adrenergic receptor locus in obesity and noninsulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Mutation of beta 3-adrenergic-receptor gene and response to treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Association of Trp64Arg mutation of the ?3-adrenergic-receptor with NIDDM and body weight gain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Genetic variation in the beta 3-adrenergic receptor in Japanese NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

A mutation of the b3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Genetic variation in the beta3-adrenergic receptor in Japanese NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Association of a genetic variation in the beta 3-adrenergic receptor gene with coronary heart disease among Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Prevalence of the Trp64Arg missense mutation of the beta3-adrenergic receptor gene in Japanese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Trp64Arg Mutation of ?-Adrenergic Receptor in Essential Hypertension Insulin Resistance and the Adrenergic System

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

UKPDS 19: Heterogeneity in NIDDM: separate contributions of IRS-1 and b3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Polymorphism of the beta3-adrenergic receptor gene affects basal metabolic rate in obese Finns.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

β3-adrenergic-receptor allele distributions in children, adolescents and young adults with obesity, underweight or anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Pharmacological characterization of a recently described human beta 3- adrenergic receptor mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

The biochemical effect of the naturally occurring Trp64-->Arg mutation on human beta3-adrenoceptor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

The human obesity gene map: the 1996 update

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

Congenital leptin deficiency is associated with severe early-onset obesity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901133-4

7 January 2021

10.1016/S0165-6147(97)01133-4

Identifiers

DOI

1 reference

7 October 2017

1 reference

PubMed ID

9458691